Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease

Reviews in the Neurosciences
Mária CsöbönyeiováL'uboš Danišovič

Abstract

The lack of effective therapies for different neurodegenerative disorders has placed huge burdens on society. To overcome the restricted capacity of the central nervous system for regeneration, the promising alternative would be to use stem cells for more effective treatment of chronic degenerative and inflammatory neurological conditions and also of acute neuronal damage and from injuries or cerebrovascular diseases. The generation of induced pluripotent stem cells from somatic cells by the ectopic expression of specific transcription factors has provided the regenerative medicine field with a new tool for investigating and treating neurodegenerative diseases, including Alzheimer's disease (AD). This technology provides an alternative to traditional approaches, such as nuclear transfer and somatic cell fusion using embryonic stem cells. However, due to a problem in standardization of certain reprogramming techniques and systems research, the induced pluripotent stem cell-based technology is still in its infancy. The present paper is aimed at a brief review of the current status in modeling and cell-based therapies for AD.

References

May 2, 2008·Annals of the New York Academy of Sciences·Annette MaczurekGerald Münch
Sep 27, 2008·Science·Matthias StadtfeldKonrad Hochedlinger
Oct 11, 2008·Science·Keisuke OkitaShinya Yamanaka
Oct 22, 2008·Nature Biotechnology·Trond AasenJuan Carlos Izpisúa Belmonte
Oct 3, 2009·Cell Stem Cell·Alexandra HaaseUlrich Martin
Feb 9, 2010·Nature Methods·Fangjun JiaJoseph C Wu
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Bao-Yang HuSu-Chun Zhang
Mar 11, 2011·Nature Reviews. Cancer·Uri Ben-David, Nissim Benvenisty
May 17, 2011·Nature·Tongbiao ZhaoYang Xu
Aug 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi BanShin-Ichi Nishikawa
Sep 9, 2011·Human Molecular Genetics·Takuya YagiNorihiro Suzuki
Sep 17, 2011·Circulation Research·Keisuke OkitaShinya Yamanaka
Jan 27, 2012·Nature·Mason A IsraelLawrence S B Goldstein
May 15, 2012·Medicinal Research Reviews·Junyan LuKeqin Kathy Li
Jun 15, 2012·Journal of Neural Transmission·Lezanne OoiGerald Münch
Sep 22, 2012·Stem Cells·Wesley W Chen, Mathew Blurton-Jones
Nov 5, 2013·Trends in Cell Biology·Alexander J FederationAlexander Meissner
Jan 5, 2014·The Journal of Biological Chemistry·Qingjian ZouLiangxue Lai
Jan 7, 2014·Cell Stem Cell·Yi Zheng, Hartmut Geiger
Jan 30, 2014·Molecular Brain·Saida OrtolanoCarlos Spuch

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
activated cell sorting
transgenic

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.